Cambridge Innovation Capital
Tier 3 Industrial
Bio
Cambridge Innovation Capital Cambridge Innovation Capital was founded in 2013 with a singular focus: funding spinouts from the University of Cambridge. The firm manages £600M in AUM, with Fund III at £250M for early-stage investments and a £100M Opportunity Fund (2025) for growth-stage deep tech and life sciences, anchored by Aviva Investors and British Patient Capital. The ecosystem integration is deep. the firm has supported 115+ founders across 45+ companies that have collectively raised £3.
Industries
BiotechQuantum ComputingSemiconductorsAI InfrastructureMedTechRobotics
Stages
SeedSeries A
Geography
UKEurope
Notable investments
- Gyroscope Therapeutics
- Bicycle Therapeutics
- Inivata
- PetMedix
- Pragmatic Semiconductor
- Riverlane
- First Light Fusion
- ORCA Computing